Cogent Biosciences (NASDAQ:COGT) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
Cogent Biosciences (NASDAQ:COGT – Get Free Report) had its target price increased by equities research analysts at JPMorgan Chase & Co. from $21.00 to $25.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm presently has an “overweight” rating on the technology company’s stock. JPMorgan Chase & Co.‘s target price […]
Cogent Biosciences (NASDAQ:COGT – Get Free Report) had its target price increased by equities research analysts at JPMorgan Chase & Co. from $21.00 to $25.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm presently has an “overweight” rating on the technology company’s stock. JPMorgan Chase & Co.‘s target price […]
